Your browser doesn't support javascript.
loading
Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon.
Lew, Thomas E; Bennett, Rory; Lin, Victor S; Whitechurch, Ashley; Handunnetti, Sasanka M; Marlton, Paula; Shen, Yandong; Mulligan, Stephen P; Casan, Joshua; Blombery, Piers; Tam, Constantine S; Roberts, Andrew W; Seymour, John F; Thompson, Philip A; Anderson, Mary A.
Affiliation
  • Lew TE; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Bennett R; Blood Cells and Blood Cancer Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
  • Lin VS; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.
  • Whitechurch A; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Handunnetti SM; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Marlton P; Blood Cells and Blood Cancer Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
  • Shen Y; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.
  • Mulligan SP; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Casan J; Department of Hematology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • Blombery P; Department of Hematology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • Tam CS; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.
  • Roberts AW; Department of Haematology, Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Seymour JF; Kolling Institute, Royal North Shore Hospital, Sydney, NSW, Australia.
  • Thompson PA; Department of Haematology, Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Anderson MA; Kolling Institute, Royal North Shore Hospital, Sydney, NSW, Australia.
Blood Adv ; 8(6): 1439-1443, 2024 Mar 26.
Article in En | MEDLINE | ID: mdl-38231032
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Leukemia, Lymphocytic, Chronic, B-Cell Limits: Humans Language: En Journal: Blood Adv Year: 2024 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Leukemia, Lymphocytic, Chronic, B-Cell Limits: Humans Language: En Journal: Blood Adv Year: 2024 Document type: Article Affiliation country: